Listed on
(Coverage)
JCR2013-2023
SJR2012-2020;2022-2023
CiteScore2011-2023
SCIE2012-2024
CC2016-2024
SCOPUS2017-2024
MEDLINE2016-2024
DOAJ2017-2024
EMBASE2016-2024
OA Info.
| OA |
oa mark
based on the information
- 2017;2018;2019;2020;2021;2022;2023;2024;2025;
|
| Keywords |
neuroscience, translational psychiatry |
| Review Process |
Anonymous peer review |
Journal info.
pages |
|
| Licences |
CC BY |
| Copyrights |
No |
| DOAJ Coverage |
Added on Date : 2012-06-11T13:51:36Z |
| Subject(s) |
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry |
Country
ENGLAND
Aime & Scopes
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod's discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.
